Radiopharm Theranostics Limited (RADX)
NASDAQ: RADX · Real-Time Price · USD
5.70
0.00 (0.00%)
At close: Aug 29, 2025, 4:00 PM
5.75
+0.05 (0.88%)
After-hours: Aug 29, 2025, 7:37 PM EDT
Radiopharm Theranostics Market Cap
Radiopharm Theranostics has a market cap or net worth of $43.31 million as of August 29, 2025. Its market cap has increased by 64.70% in one year.
Market Cap
43.31M
Enterprise Value
23.01M
1-Year Change
64.70%
Ranking
Category
Stock Price
$5.70
Market Cap Chart
Since November 25, 2021, Radiopharm Theranostics's market cap has decreased from $72.85M to $43.31M, a decrease of -40.54%. That is a compound annual growth rate of -12.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 43.31M | 32.95% |
| Dec 31, 2024 | 32.58M | 73.79% |
| Dec 29, 2023 | 18.75M | -20.04% |
| Dec 30, 2022 | 23.45M | -67.78% |
| Dec 31, 2021 | 72.76M | -0.12% |
| Nov 25, 2021 | 72.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 660.76B |
| Johnson & Johnson | 425.05B |
| AbbVie | 368.08B |
| UnitedHealth Group | 272.09B |
| AstraZeneca | 248.21B |
| Novartis AG | 243.97B |
| Novo Nordisk | 243.46B |
| Abbott Laboratories | 229.03B |